Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock


Lab Corp Beats Estimates – Analyst Blog

Source: http://www.zacks.com/stock/news/26321/Lab+Corp+Beats+Estimates+-+Analyst+Blog
Posted on Thursday, October 22nd, 2009 | In Investing Lessons, Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -

This morning, Laboratory Corporation of America Holdings (LH) reported strong third quarter financials. The company’s earnings per share of $1.22 surpassed the Zacks Consensus Estimate of $1.15 as well as the $1.10 reported in the year-ago period. Revenues recorded a 4.4% year-over-year increase to $1.2 billion, driven by a 0.7% increase in testing volume (measured by accessions) and a 3.7% increase in revenue per accession.

Lab Corp’s gross margin reported an improvement of 137 basis points during the reported quarter. While revenues increased 4.4%, cost of goods sold grew by 2%. The company recorded an improvement in operating margin (excluding restructuring and other special charges) by 60 basis points to 20% compared to 19.4% in the year-ago period.

At the end of the September quarter, Lab Corp had $126.8 million of cash and short-term investments, down from $219.7 million at the end of December 2008. Free cash flow position improved significantly to $560.6 million at the end of the reported quarter compared to $445.2 million in the corresponding period.

To enhance shareholder value, the company repurchased $165.1 million of stock representing approximately 2.4 million shares during the quarter with another 180.2 million of repurchase authorization remaining under its share repurchase plan. Lab Corp had $70.8 million remaining under its $500 million revolving credit facility.

Back in August, Lab Corp announced the completion of the formalities related to the acquisition of Monogram Biosciences. Following this, Monogram became a wholly owned subsidiary of Lab Corp. Per the deal, announced in June 2009 all outstanding shares of Monogram were to be acquired by Lab Corp at $4.55 per share.

In addition to posting a strong third quarter performance, Lab Corp provided its 2009 full-year guidance. The company now expects its earnings per share in the range of $4.84 – $4.89, not taking into consideration the dilution due to the acquisition of Monogram.
Read the full analyst report on “LH”
Zacks Investment Research

Last 5 posts by Zacks Market Commentaries





About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries

Leave a Reply

Name

Email (kept private)

Website









No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.